Home/Filings/4/0001765581-25-000051
4//SEC Filing

Pearce Samantha 4

Accession 0001765581-25-000051

CIK 0001232524other

Filed

Aug 6, 8:00 PM ET

Accepted

Aug 7, 6:06 PM ET

Size

5.1 KB

Accession

0001765581-25-000051

Insider Transaction Report

Form 4
Period: 2025-08-05
Pearce Samantha
EVP, Chief Commercial Officer
Transactions
  • Tax Payment

    Ordinary Shares

    2025-08-05$116.10/sh577$66,99040,815 total
Footnotes (2)
  • [F1]Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
  • [F2]The Reporting Person acquired 166 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 30, 2025.

Issuer

Jazz Pharmaceuticals plc

CIK 0001232524

Entity typeother

Related Parties

1
  • filerCIK 0001805688

Filing Metadata

Form type
4
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 6:06 PM ET
Size
5.1 KB